International Journal of Keratoconus and Ectatic Corneal Diseases

Register      Login

VOLUME 4 , ISSUE 2 ( May-August, 2015 ) > List of Articles

RESEARCH ARTICLE

Corneal Cross-linking can halt the Progression of Keratoconus, but what is the Best Approach to Treatment?

Frederik Raiskup, Mark Hillen

Citation Information : Raiskup F, Hillen M. Corneal Cross-linking can halt the Progression of Keratoconus, but what is the Best Approach to Treatment?. Int J Kerat Ect Cor Dis 2015; 4 (2):47-51.

DOI: 10.5005/jp-journals-10025-1097

Published Online: 01-08-2015

Copyright Statement:  Copyright © 2015; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Raiskup F, Hillen M. Corneal Crosslinking can halt the Progression of Keratoconus, but what is the Best Approach to Treatment? Int J Kerat Ect Cor Dis 2015; 4(2):47-51.


PDF Share
  1. Longitudinal changes in visual acuity in keratoconus. Invest Ophthalmol Vis Sci 2006;47(2):489-500.
  2. Estimation of the incidence and factors predictive of corneal scarring in the Collaborative longitudinal evaluation of keratoconus (CLEK) Study. Cornea 2006;25(1):16-25.
  3. The lifetime economic burden of keratoconus: a decision analysis using a markov model. Am J Ophthalmol 2011;151(5):768-773.
  4. Corneal crosslinking with riboflavin and ultraviolet A. I. Principles. Ocul Surf 2013;11(2):65-74.
  5. Age-related long-term functional results after riboflavin UV: a corneal cross-linking. J Ophthalmol 2011;2011:608041.
  6. Riboflavin-UVA-induced corneal collagen cross-linking in pediatric patients. Cornea 2012;31(3):227-231.
  7. Riboflavin/ultravioleta- induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 2003;135(5):620-627.
  8. Corneal collagen crosslinking with riboflavin and ultraviolet—a light in progressive keratoconus: 10-year results. J Cataract Refract Surg 2015;41(1):41-46.
  9. Epithelium-off photochemical corneal collagen cross-linkage using riboflavin and ultraviolet A for keratoconus and keratectasia: a systematic review and meta-analysis. Ocul Surf 2014;12(3):202-214.
  10. Refractive and topographic results of benzalkonium chlorideassisted transepithelial crosslinking. J Cataract Refract Surg 2012;38(6):1000-1005.
  11. Biomechanical and histological changes after corneal crosslinking with and without epithelial debridement. J Cataract Refract Surg 2009;35(3): 540-546.
  12. Brillouin microscopy of collagen crosslinking: noncontact depth-dependent analysis of corneal elastic modulus. Invest Ophthalmol Vis Sci 2013;54(2):1418-1425.
  13. Transepithelial corneal collagen crosslinking for progressive keratoconus: 24-month clinical results. J Cataract Refract Surg 2013;39(8):1157-1163.
  14. Pharmacological modification of the epithelial permeability by benzalkonium chloride in UVA/Riboflavin corneal collagen cross-linking. Curr Eye Res 2010;35(8):715-721.
  15. Transepithelial corneal collagen crosslinking in keratoconus. J Refract Surg 2010;26(12):942-948.
  16. Biomechanical efficacy of collagen crosslinking in porcine cornea using a femtosecond laser pocket. Cornea 2014;33(3):300-305.
  17. Collagen cross-linking in early keratoconus with riboflavin in a femtosecond laser-created pocket: initial clinical results. J Refract Surg 2009;25(11):1034-1037.
  18. Evaluating in vivo delivery of riboflavin with coulomb-controlled iontophoresis for corneal collagen cross-linking: a pilot study. Invest Ophthalmol Vis Sci 2014;55(4):2731-2738.
  19. Iontophoresis transcorneal delivery technique for transepithelial corneal collagen crosslinking with riboflavin in a rabbit model. Invest Ophthalmol Vis Sci 2014 [Epub ahead of print].
  20. Corneal crosslinking: intrastromal riboflavin concentration in iontophoresisassisted imbibition versus traditional and transepithelial techniques. Am J Ophthalmol 2014;157(3):623-630.
  21. Transepithelial iontophoresis corneal collagen cross-linking for progressive keratoconus: initial clinical outcomes. J Refract Surg 2014; 30(11):746-753.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.